White Guide and Orange Guide Formatting Project - Pfizer

Orange Guide – Chapter 5: Interactions with Health Systems and Medical Groups
Chapter 5: INTERACTIONS WITH HEALTH SYSTEMS
AND MEDICAL GROUPS
CONTENTS
Interactions with Health Systems and Medical Groups
Introduction ....................................................................................................................................................................2
Key Points to Ensure Compliance ......................................................................................................................... 3
Approved Materials ....................................................................................................................................................... 4
Use of Disclaimers ......................................................................................................................................................... 9
Product Messaging Risks .............................................................................................................................................. 9
Collaborations .............................................................................................................................................................. 10
Appropriate Value ............................................................................................................................................... 11
Metrics .................................................................................................................................................................. 12
Avoid Combining Types of Transactions .................................................................................................................... 15
Medical Activities ......................................................................................................................................................... 16
FOR MORE INFORMATION ........................................................................................................................................ 18
96
Rev. 09/12
Page 1 of 18